Literature DB >> 17580291

Selective pressures for and against genetic instability in cancer: a time-dependent problem.

Natalia L Komarova1, Alexander V Sadovsky, Frederic Y M Wan.   

Abstract

Genetic instability in cancer is a two-edge sword. It can both increase the rate of cancer progression (by increasing the probability of cancerous mutations) and decrease the rate of cancer growth (by imposing a large death toll on dividing cells). Two of the many selective pressures acting upon a tumour, the need for variability and the need to minimize deleterious mutations, affect the tumour's 'choice' of a stable or unstable 'strategy'. As cancer progresses, the balance of the two pressures will change. In this paper, we examine how the optimal strategy of cancerous cells is shaped by the changing selective pressures. We consider the two most common patterns in multistage carcinogenesis: the activation of an oncogene (a one-step process) and an inactivation of a tumour-suppressor gene (a two-step process). For these, we formulate an optimal control problem for the mutation rate in cancer cells. We then develop a method to find optimal time-dependent strategies. It turns out that for a wide range of parameters, the most successful strategy is to start with a high rate of mutations and then switch to stability. This agrees with the growing biological evidence that genetic instability, prevalent in early cancers, turns into stability later on in the progression. We also identify parameter regimes where it is advantageous to keep stable (or unstable) constantly throughout the growth.

Entities:  

Mesh:

Year:  2008        PMID: 17580291      PMCID: PMC2605501          DOI: 10.1098/rsif.2007.1054

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  53 in total

Review 1.  A critical role for telomeres in suppressing and facilitating carcinogenesis.

Authors:  S E Artandi; R A DePinho
Journal:  Curr Opin Genet Dev       Date:  2000-02       Impact factor: 5.578

2.  Local regulation of homeostasis favors chromosomal instability.

Authors:  Franziska Michor; Yoh Iwasa; Natalia L Komarova; Martin A Nowak
Journal:  Curr Biol       Date:  2003-04-01       Impact factor: 10.834

3.  A stochastic carcinogenesis model incorporating genomic instability fitted to colon cancer data.

Authors:  M P Little; E G Wright
Journal:  Math Biosci       Date:  2003-06       Impact factor: 2.144

4.  Resolving the evolutionary paradox of genetic instability: a cost-benefit analysis of DNA repair in changing environments.

Authors:  Jarle Breivik; Gustav Gaudernack
Journal:  FEBS Lett       Date:  2004-04-09       Impact factor: 4.124

5.  Mechanisms of cell death associated with death-inducing factors from genomically unstable cell lines.

Authors:  Shruti Nagar; Leslie E Smith; William F Morgan
Journal:  Mutagenesis       Date:  2003-11       Impact factor: 3.000

Review 6.  Radiation-induced genomic instability: radiation quality and dose response.

Authors:  Leslie E Smith; Shruti Nagar; Grace J Kim; William F Morgan
Journal:  Health Phys       Date:  2003-07       Impact factor: 1.316

7.  The role of chromosomal instability in tumor initiation.

Authors:  Martin A Nowak; Natalia L Komarova; Anirvan Sengupta; Prasad V Jallepalli; Ie-Ming Shih; Bert Vogelstein; Christoph Lengauer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-21       Impact factor: 11.205

8.  Mutation-selection networks of cancer initiation: tumor suppressor genes and chromosomal instability.

Authors:  Natalia L Komarova; Anirvan Sengupta; Martin A Nowak
Journal:  J Theor Biol       Date:  2003-08-21       Impact factor: 2.691

9.  Inactivation of hCDC4 can cause chromosomal instability.

Authors:  Harith Rajagopalan; Prasad V Jallepalli; Carlo Rago; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christoph Lengauer
Journal:  Nature       Date:  2004-03-04       Impact factor: 49.962

10.  Evolutionary dynamics of mutator phenotypes in cancer: implications for chemotherapy.

Authors:  Natalia L Komarova; Dominik Wodarz
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

View more
  11 in total

1.  Optimality in the development of intestinal crypts.

Authors:  Shalev Itzkovitz; Irene C Blat; Tyler Jacks; Hans Clevers; Alexander van Oudenaarden
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

Review 2.  Dissecting cancer through mathematics: from the cell to the animal model.

Authors:  Helen M Byrne
Journal:  Nat Rev Cancer       Date:  2010-03       Impact factor: 60.716

3.  Stress-induced mutagenesis and complex adaptation.

Authors:  Yoav Ram; Lilach Hadany
Journal:  Proc Biol Sci       Date:  2014-10-07       Impact factor: 5.349

4.  Fastest time to cancer by loss of tumor suppressor genes.

Authors:  Cynthia Sanchez-Tapia; Frederic Y M Wan
Journal:  Bull Math Biol       Date:  2014-10-23       Impact factor: 1.758

Review 5.  Hybrid models of tumor growth.

Authors:  Katarzyna A Rejniak; Alexander R A Anderson
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2011 Jan-Feb

Review 6.  Cancer models, genomic instability and somatic cellular Darwinian evolution.

Authors:  Mark P Little
Journal:  Biol Direct       Date:  2010-04-20       Impact factor: 4.540

7.  Chromosomal instability and cancer: not just one CINgle mechanism.

Authors:  C Richard Boland; Natalia L Komarova; Ajay Goel
Journal:  Gut       Date:  2009-02       Impact factor: 23.059

8.  Evolution of genetic instability in heterogeneous tumors.

Authors:  Ani D Asatryan; Natalia L Komarova
Journal:  J Theor Biol       Date:  2016-01-27       Impact factor: 2.691

9.  Hyperbolastic modeling of tumor growth with a combined treatment of iodoacetate and dimethylsulphoxide.

Authors:  Wayne M Eby; Mohammad A Tabatabai; Zoran Bursac
Journal:  BMC Cancer       Date:  2010-09-23       Impact factor: 4.430

10.  Modelling the evolution of genetic instability during tumour progression.

Authors:  Ruchira S Datta; Alice Gutteridge; Charles Swanton; Carlo C Maley; Trevor A Graham
Journal:  Evol Appl       Date:  2012-11-26       Impact factor: 5.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.